This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
BlogNoul’s story on sustainability, cultures
Noul’s story on sustainability, cultures
and impact business
- Cervical Health Awareness Month – Preventing Cervical Cancer with Early Detection and Pap Smears
2025.01.21
- NOUL Signs Major Supply Agreement with Limbach Gruppe SE to Enhance Diagnostic Services
2025.01.17
- CES 2025 Highlights: NOUL’s Biotechnological Innovations and ESG Strategies in Diagnostics
2025.01.14
- 3 Comprehensive Malaria Diagnostic Solutions: Microscopic Examination, RDTs, and PCR for Accurate Detection
2025.01.10
- NGSI Technology: Revolutionizing Immunohistochemistry Staining with Hydrogel-Based Innovation
2025.01.07
- 6 Cervical Health Indicators Analyzed by miLab™ CER – HSIL, LSIL, NILM, ASC-H, ASC-US, and SCC
2025.01.03
- Revolution of Automated Diagnostics Solution: NOUL’s miLab™ BCM Expands to Europe
2024.12.31
- 3 Visible Signs of Cervical Cancer: Hypermenorrhea, Pelvic Pain, and Foul-Smelling Discharge
2024.12.27
- Point-of-Care Testing Revolution: AI-Powered Malaria Diagnosis with miLab™ MAL
2024.12.24